Overview
Wilna Oosthuyzen practices practicing medicine in Edinburgh, United Kingdom.
Her clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), and Low Sodium Level.
She is actively involved in clinical research, co-authoring 23 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Wilna Oosthuyzen
Is Wilna Oosthuyzen a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Wilna Oosthuyzen is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Wilna Oosthuyzen participate in research or clinical trials?
Yes. Wilna Oosthuyzen has published 23 articles and abstracts on conditions like COVID-19. You can view a list of Wilna Oosthuyzen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Ms. Oosthuyzen isExperienced. Learn about COVID-19.
- Low Sodium LevelMs. Oosthuyzen isExperienced. Learn about Low Sodium Level.
- Severe Acute Respiratory Syndrome (SARS)Ms. Oosthuyzen isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).